Xtant Medical Holdings, Inc.
XTNT
$0.60
$0.011.83%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 126.04% | 191.95% | 101.32% | 26.45% | -154.41% |
| Total Depreciation and Amortization | 8.20% | 17.13% | 6.87% | 12.88% | 21.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.80% | -31.70% | 30.79% | 16.10% | 113.73% |
| Change in Net Operating Assets | -39.05% | -19.82% | 58.19% | 10.85% | 134.70% |
| Cash from Operations | 368.45% | 125.08% | 122.21% | 172.68% | 55.19% |
| Capital Expenditure | 79.56% | 35.11% | -54.08% | -85.12% | -843.50% |
| Sale of Property, Plant, and Equipment | 14.74% | -41.67% | -51.52% | 0.00% | 533.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 332.90% | 33.96% | -69.58% | 75.49% | 56.85% |
| Total Debt Issued | -3.70% | -21.88% | -17.37% | 14.58% | 40.88% |
| Total Debt Repaid | -22.10% | 5.75% | -4.92% | -18.82% | -28.02% |
| Issuance of Common Stock | -- | -- | -- | -- | -68.10% |
| Repurchase of Common Stock | 40.86% | -- | 47.06% | 52.11% | 21.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 91.62% | 92.20% | -172.38% | -132.67% |
| Cash from Financing | -208.60% | -89.71% | -117.74% | -362.77% | -58.63% |
| Foreign Exchange rate Adjustments | 300.00% | -58.33% | 95.92% | -241.56% | 139.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.13% | 87.59% | 39.49% | 69.39% | -62.61% |